Sunday , 23 February 2025
Health

GLP-1 agonists are transforming the weight loss market. Experts weighed in on the changes they’re seeing, speaking in a panel discussion during the MedCity News INVEST Conference in Chicago.

The post Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush appeared first on MedCity News.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

A paper by Proudman et al. (2024) finds that doing so would...

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird...

Hospitals are adopting AI technology more than ever before, but they still...

This fact sheet provides an overview of the history of the Kemp-Kasten...